Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788
Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver function in X-linked myotubular myopathy and autosomal dominant centronuclear myopathy: Data of the unite-CNM study.

Journal of neuromuscular diseases·2025
Same author

Early postnatal hepatocyte transplantation in a child with molybdenum cofactor deficiency type B.

Molecular genetics and metabolism·2025
Same author

Correction to: Patient-Specific Mandibular Reconstruction Plates Increase Accuracy and Long-Term Stability in Immediate Alloplastic Reconstruction of Segmental Mandibular Defects.

Journal of maxillofacial and oral surgery·2023
Same author

Patient-Specific Mandibular Reconstruction Plates Increase Accuracy and Long-Term Stability in Immediate Alloplastic Reconstruction of Segmental Mandibular Defects.

Journal of maxillofacial and oral surgery·2020
Same author

Substance use among treatment seeking Indian adolescent girls: Are they unique?

Asian journal of psychiatry·2019
Same author

Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non-alcoholic fatty liver disease.

Pediatric obesity·2018
Same journal

Dynamical Analysis of an Impulsive Model of Cancer Cell Populations Under Radiotherapy.

Mathematical medicine and biology : a journal of the IMA·2026
Same journal

Mathematical modelling of biofilm growth on medical implants incorporating nutrient-dependent phenotypic switching.

Mathematical medicine and biology : a journal of the IMA·2026
Same journal

Modeling opioid use disorder in hand surgery patients.

Mathematical medicine and biology : a journal of the IMA·2026
Same journal

Tuning Butterworth filter's parameters in SPECT reconstructions via kernel-based Bayesian optimization with a no-reference image evaluation metric.

Mathematical medicine and biology : a journal of the IMA·2025
Same journal

Mechanical cell competition in a model of epithelial layer with size dependent proliferation.

Mathematical medicine and biology : a journal of the IMA·2025
Same journal

The effect of cell adhesion on the interpretation of scratch assay data: a non-local model.

Mathematical medicine and biology : a journal of the IMA·2025
See all related articles

Related Experiment Video

Updated: Feb 19, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

Modelling recurrence and second cancer risks induced by proton therapy.

V S K Manem1, A Dhawan2

  • 1Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.

Mathematical Medicine and Biology : a Journal of the IMA
|November 7, 2017
PubMed
Summary
This summary is machine-generated.

Proton therapy offers improved tumor control probability (TCP) and reduced secondary cancer risks compared to photon therapy. This study models these benefits, providing a framework for assessing proton radiation

More Related Videos

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

9.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

944

Related Experiment Videos

Last Updated: Feb 19, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Detecting Anastasis In Vivo by CaspaseTracker Biosensor
20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

9.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

944

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Cancer Biology

Background:

  • Proton therapy is increasingly used for various cancers.
  • Assessing tumor control probability (TCP) and secondary cancer risks is crucial for treatment optimization.

Purpose of the Study:

  • To investigate tumor control probability (TCP), relapse time, and secondary cancer risks associated with proton beam radiation therapy.
  • To incorporate tumor relapse kinetics into the TCP framework for proton therapy.
  • To evaluate proton therapy's efficacy and safety compared to photon therapy.

Main Methods:

  • Utilized a biologically motivated mathematical model (initiation-inactivation-proliferation formalism).
  • Incorporated in vitro data on linear energy transfer (LET) for cell killing and mutation induction.
  • Calculated TCP and secondary cancer risks for protons within clinical LET ranges (8 keV/μm for tumors, 1-3 keV/μm for organs at risk).

Main Results:

  • Proton therapy significantly reduces the risk of secondary malignancies compared to photon therapy.
  • Equivalent dosing regimens with proton therapy achieve better tumor control.
  • Proton therapy leads to a reduced primary recurrence outcome, particularly in hypo-fractionated regimens.

Conclusions:

  • The developed theoretical framework provides a method for assessing proton radiation TCP, relapse, and carcinogenic effects.
  • Proton therapy presents a favorable alternative to photon therapy for cancer treatment, offering improved outcomes and reduced risks.
  • Further research with more cell lines can refine model parameters and reduce uncertainties.